ABVC BioPharma Shares Outstanding 2006-2021 | ABVC

ABVC BioPharma shares outstanding from 2006 to 2021. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
ABVC BioPharma Annual Shares Outstanding
(Millions of Shares)
2020 20
2019 17
2018 12
2017 12
2017 12
2016 11
2015 9
2014 0
2013 0
2012 0
2011 0
2010 0
2009 32
2008
2008 32
2007
ABVC BioPharma Quarterly Shares Outstanding
(Millions of Shares)
2021-06-30 24
2021-03-31 24
2020-12-31 20
2020-09-30 19
2020-06-30 19
2020-03-31 19
2019-12-31 17
2019-09-30 19
2019-06-30 17
2019-03-31 15
2018-12-31 12
2018-09-30 12
2018-06-30 12
2018-03-31 12
2017-12-31 12
2017-09-30 12
2017-06-30 12
2017-03-31 12
2016-12-31 12
2016-09-30
2016-06-30 12
2016-03-31 12
2015-12-31 9
2015-09-30 9
2015-06-30 10
2015-03-31 0
2014-12-31 10
2014-09-30
2014-06-30 10
2014-03-31 0
2013-12-31 0
2013-09-30
2013-06-30 0
2012-09-30
2012-06-30
2012-03-31 0
2011-12-31 0
2011-09-30 0
2011-06-30 0
2011-03-31 0
2010-12-31 0
2010-09-30 0
2010-06-30 0
2010-03-31 0
2009-09-30
2009-06-30 0
2009-03-31 0
2008-09-30
2008-06-30 0
2008-03-31 0
2007-06-30 0
2007-03-31 0
2006-09-30 0
2006-06-30 0
2006-03-31 0
2005-09-30 0
2005-06-30 0
2005-03-31 0
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.058B $0.000B
ABCV BIOPHARMA identifies & commercializes drugs & medical devices developed. ABCV BIOPHARMA, formerly known as AMER BRIVISION, is based in FREMONT, CA.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $132.971B 8.85
Bio-Rad Laboratories (BIO.B) United States $22.624B 48.22
QIAGEN (QGEN) Netherlands $12.001B 20.32
Biohaven Pharmaceutical Holding (BHVN) United States $8.691B 0.00
Emergent Biosolutions (EBS) United States $2.870B 6.92
Arcus Biosciences (RCUS) United States $2.690B 0.00
Myovant Sciences (MYOV) United Kingdom $2.182B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.045B 0.00
Zymeworks (ZYME) Canada $1.373B 0.00
Ambrx Biopharma (AMAM) United States $0.501B 0.00
SQZ Biotechnologies (SQZ) United States $0.442B 0.00
Enzo Biochem (ENZ) United States $0.174B 51.29